Source: Pharmacy Times articles
With each increase in lipoprotein(a) level in patients with atherosclerotic cardiovascular disease (ASCVD), there was a corresponding increase in risk of experiencing an ASCVD event.
Read More
by MM360 Staff | May 22, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
With each increase in lipoprotein(a) level in patients with atherosclerotic cardiovascular disease (ASCVD), there was a corresponding increase in risk of experiencing an ASCVD event.
Read More